PTPN1 and Impaired glucose tolerance: Administration of safranal (20 mg/kg, PO, for 2 weeks) led to dephosphorylation of the insulin receptor via inhibition of protein tyrosine phosphatase 1B (PTP1B), which plays a role in insulin signaling and improved impaired glucose tolerance (168).